Search
for
Sort by
Research 31–60 of 133
- Skin disorders in Parkinson’s disease: potential biomarkers and risk factors
- Premature graying of hair
- Kin‐cohort analysis of <i>LRRK2</i>‐G2019S penetrance in Parkinson's disease
- A preliminary study of finasteride in Tourette syndrome
- Drug-Induced Hair Disorders
- Desferrioxamine treatment of aceruloplasminemia: Long‐term follow‐up
- Hair problems in women
- 5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction
- Alopecia in Association with Malignancy: A Review
- Hair Loss in Systemic Disease
- NON-PSORALEN TREATMENT OF VITILIGO. PART II. LESS COMMONLY USED AND EXPERIMENTAL THERAPIES
- Pathological findings in a case of stiff person syndrome with anti‐GAD antibodies
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- Spontaneous cutaneous adverse drug reaction reports—An analysis of a 10‐year dataset in Singapore
- Hair loss
- A machine learning and network framework to discover new indications for small molecules
- Telogen Effluvium Associated with Albendazole Therapy
- An overview of management of drug-induced hair and nail disorders
- The spectrum of nephrocutaneous diseases and associations
- Significance of iron status in hair loss in women
- Frontotemporal dementia with parkinsonism presenting as posterior cortical atrophy
- Repositioning Old Drugs for New Battles: The Expanding Role of Drug Repurposing in Cancer, Inflammation, and Metabolic Disease.
- Interpretation of Laboratory Data and General Physical Examination by Pharmacists
- Psychotropic Treatment of Psychodermatologic Disorders
- A Comprehensive Review on Current and Future Trends of Nanoemulsions in Modern Cosmetics and Pharmaceuticals
- Androgens and Parkinson’s disease: the role in humans and in experiment
- Sebum Production
- British Hair and Nail Society
- Untangling the hairy issue of iron deficiency: Making progress
- Interpenetrating gelatin/sodium alginate hydrogel with controlled PRP lysate delivery for accelerating diabetic wound healing with reduced scarring